News
Jemperli label extended to include rectal cancer
GSK's PD-1 inhibitor Jemperli has been cleared by the FDA as the first pre-operative cancer immunotherapy for rectal cancer.
News
AI tool uses face photos to predict cancer survival
Researchers have developed an AI model, trained on millions of facial images, that can directly predict survival risk in patients with cancer.
News
Roche offers $15bn for strategic-level deal with Hansoh
A year after signing a first deal with Hansoh worth up to $1.45 billion, Roche has returned for another that could be more than 10 times larger.
News
Data reveal is promising for GSK's lung cancer drug ris-rez
The first data from GSK's international trial of B7-H3-targeted ADC ris-rez in small cell lung cancer back up earlier results from a Chinese study.
News
Cancer biotech Nouscom adds €120m, and other financings
A €120m Series D for Swiss biotech Nouscom will support trials of a Lynch syndrome vaccine, with Soufflé, Estuary, and Microbiotica also raising cash.
News
Views & Analysis
Deep Dive
Editor's Picks
Editor's Picks
